第7回CSJ化学フェスタ2017 「最優秀ポスター発表 …

1 7 CSJ 2017 CSJ JNC 10 17 19 7 CSJ 2017 CSJ 1) 2) R&D 3,000 8 1,073 1) 2) 3) 3 10 CSJ 198 CSJ CSJ (10 ) [ ] P8-013 ( ) EPR [ ] P2-020 ( ) [ ] P5-022 ( ) a P9-032 ( ) 2H- [ ] P6-080 ( ) [ ] P7-080 ( )

2 [ ] P4-079 ( ) [ ] P1-098 ( ) [ ] P1-128 ( ) P6-128 ( ) 198 [ ] P1-001 ( ) P1-006 ( ) Orbital-free P1-008 ( ) P1-015 ( ) P2-003 ( ) KR2 Na+ P2-004 ( ) P2-012 ( ) - P4-005 ( ) P4-006 ( ) P4-012 Hao Yingquan ( ) Switchable polar solvent based on mixture of DBU and alcohol by CO2 P6-014 ( ) P6-016 ( ) P8-003 ( ) P8-007 ( ) P8-009 ( ) P9-011 ( ) P9-015 ( )

3 [ ] P2-024 ( ) P3-008 ( ) P3-013 ( ) Co NO P3-014 ( ) P5-003 ( ) Au25(SR)5(PR3)10Cl Pd P5-007 ( ) /2- / P5-010 ( ) P6-019 ( ) DNA P6-022 ( ) CsH2PO4-xPO4 P6-030 ( ) DNA 1 P7-003 ( ) P7-005 ( ) P7-012 ( ) [ ] P1-025 ( ) P1-026 ( ) P1-030 ( ) P1-033 ( ) Pd(II) P1-034 ( ) 7 P1-039 ( ) 2 P1-042 ( ) Cp*Rh(III) C H 1,4- P2-038 ( ) (I)

4 P2-039 ( ) NA (I): P2-042 ( ) P2-051 ( ) P2-053 ( ) P3-018 ( ) Lewis Lewis P3-024 ( ) P3-028 ( ) 9 P3-032 ( ) P3-033 ( ) -N- P3-042 ( ) P4-021 ( ) 1,3- P4-030 ( ) o- P4-032 ( )

5 PH Cy5 P4-037 ( ) P5-023 ( ) P5-035 ( ) [1,2]-Phospha-Brook P5-040 ( ) P6-038 ( ) - (II) - P6-044 ( ) P6-045 ( ) P6-047 ( ) C(sp3) H P6-055 ( ) P6-056 ( ) P6-059 ( ) 2,7- P7-031 ( ) P7-033 ( ) N- P7-041 ( ) P8-022 ( ) P8-023 ( ) sp3 P8-027 ( ) P8-030 ( ) 2- P8-031 ( ) P8-042 ( ) P8-044 ( ) P9-023 ( ) sp2 P9-028 ( )

6 -Friedel Crafts P9-039 ( ) DAST P9-045 ( ) NHC Termicalcicolanone B [ ] P1-054 ( ) P1-062 ( ) (II) P2-061 ( ) P3-049 ( ) Pd(II) P3-057 ( ) P3-058 ( ) P3-060 FerreiradaRosa PedroPaulo ( ) Tb(III) P4-046 ( ) 2,2 - P4-048 ( ) (II) P4-049 ( ) Au P5-049 ( ) Z P5-051 ( ) P5-058 ( ) Water-soluble lanthanide complexes with a helicate -skeleton for strong luminescence in a wide pH region P5-060 ( ) (I) P6-072 ( ) P6-076 ( ) N- P7-056 ( ) CH- P7-062 ( ) Pd(II) P8-051 ( )

7 P8-059 ( ) - P9-051 ( ) 10 P9-059 ( ) (III) P9-060 ( ) Rh [ ] P1-069 ( ) P1-077 ( ) P1-078 ( ) P2-077 ( ) FUT8 P2-085 ( ) Violaceoid A B P2-088 ( ) Cynaropicrin P3-067 ( ) 1 PRX1 P3-077 ( ) [4+4] P4-063 ( ) P4-064 ( ) iPS P5-070 ( ) P5-074 ( ) P5-075 ( ) P5-079 ( ) P6-085 ( ) P6-090 ( ) Creation of the ischemia-selective oligonucleotide therapeutics system with intracellular condition-responsive Peptide Ribonucleic Acids (PRNAs).

8 Synthesis and characteristics of hemi-gapmer type chimeric PRNA derivatives for the catalytic oligonucleotide therapeutics system P6-092 ( ) P6-093 ( ) N P7-078 ( ) P8-070 ( ) P8-075 ( ) P9-069 ( ) P9-079 ( ) NMR P9-080 ( ) [ ] P1-083 ( ) P1-086 ( ) P1-088 ( ) Sub-10 nm - P1-090 ( ) P2-098 ( ) P2-101 ( ) P2-105 ( ) P3-083 ( ) P3-084 ( ) P3-090 ( ) P4-078 ( ) P4-082 ( ) P5-084 ( ) P5-099 ( )

9 ABC P6-103 ( ) (N- ) P6-113 ( ) P6-114 ( ) P7-087 ( )